LINC02904: A Potential Drug Target Or Biomarker (G286122)

Target Name: LINC02904

NCBI ID: G286122

LINC02904

Other Name(s): long intergenic non-protein coding RNA 2904 | Long intergenic non-protein coding RNA 2904, transcript variant 1 | C8orf31

LINC02904: A Potential Drug Target Or Biomarker

LINC02904 is a long intergenic non-protein coding RNA (lncRNA) molecule that has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is located between the genes P161 and P162 on chromosome 16, and it is characterized by its ability to interact with the protein encoded by the SLC30F1 gene.

The SLC30F1 gene is a member of the SLC gene family that is responsible for the production of various proteins that are involved in a wide range of cellular processes, including cell signaling, ion transport, and protein-protein interactions. The SLC30F1 gene has been implicated in the development of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

LINC02904 has been shown to interact with the SLC30F1 protein in a variety of cellular contexts. For example, studies have shown that LINC02904 can physically interact with the SLC30F1 protein in a cell-free culture system, and that this interaction is dependent on the presence of the protein encoded by the EIF4F gene. Additionally, LINC02904 has been shown to play a role in the regulation of the SLC30F1 gene, as well as the expression of other genes that are involved in cellular processes.

The potential implications of LINC02904 as a drug target or biomarker are significant. If LINC02904 is indeed involved in the regulation of the SLC30F1 gene, it is possible that targeting this molecule could be a useful strategy for the development of new treatments for a variety of diseases. For example, LINC02904 could be used as a target for cancer treatments, as the SLC30F1 gene has been implicated in the development of many types of cancer. Additionally, LINC02904 could be used as a biomarker for a variety of diseases, as its interaction with the SLC30F1 protein has been shown to be dependent on the presence of this protein.

In conclusion, LINC02904 is a promising candidate for drug targeting or biomarker research. Further studies are needed to fully understand its role in cellular processes and its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2904

The "LINC02904 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02904 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets